Skip to main content
  • Meeting abstract
  • Open access
  • Published:

Hypertriglyceridemic waist phenotype indicates insulin resistance in adolescents: validation study front hyperglycemic clamp-Brazilian Metabolic Syndrome Study (BRAMS)

Background

The increase in levels of triglycerides (TG) and waist circumference (WC) characterize the phenotype of hypertriglyceridemic waist (HTGW phenotype) that predicts cardiovascular risk in adults to join the atherogenic triad: hyperinsulinemia, high concentrations of Apo -B and small dense LDL particles. Recent studies have demonstrated that metabolic syndrome (MS) is a marker and cardiovascular alterations in adolescents.

Objective

To investigate the association of HTGW phenotype with metabolic syndrome (MS) and insulin resistance (IR) assessed by hyperglycemic clamp in adolescents.

Materials and methods

Cross-sectional study with 847 adolescents (10-19 yrs., 537 girls). It assessed pubertal stage (self-assessment-Tanner), anthropometric and laboratory parameters. IR assessed by HOMA-IR method and the hyperglycemic clamp (glucose infusion rate adjusted for lean mass [TIGMM]) n=77; IR considered HOMA-IR> 75th percentile HTGW Phenotype defined by the presence of TG> 100 mg/dL and dc> 75 cm in pubertal girls (sensitivity (S) 71.2% and (E) specificity 61.8%), CC> 84 cm in post-pubertal girls (S: 84.7% and E 63%), WC> 86 cm in pubescent boys (S 72.9% and 80.7% E) and WC >94 cm in post-pubescent boys (85.5% S and E 82.4%). Cutoff points for CC determined by ROC curves, considering the value of a larger sum of S and E to IR identification, stratified by gender and pubertal stage.

Results

The phenotype (HTGW phenotype versus healthy) was associated with the highest average total cholesterol (183±33 vs 151±27), LDL (111±30 vs 88±24), systolic blood pressure (119±13 vs 109±13), diastolic pressure (76±8 vs 69±10), HOMA-IR index (4.7±2.9 vs. 1.8±1.1), insulin (13±21.8 vs 9±5); Glucose (87±10 vs 81±10) and lower HDL levels (42±11 vs 51±11) compared to healthy; p <0.001.

Conclusion

The Results demonstrate the usefulness of the phenotype of hypertriglyceridemic waist identify the presence of insulin resistance and metabolic syndrome in adolescents' population in plan and in clinical practice.

Figure 1
figure 1

Distribution of the components of the metabolic syndrome in the presence of the Hypertriglyceridemic waist phenotype.

Figure 2
figure 2

Hypertriglyceridemic waist phenotype compared in the presence of IR assessed by HOMA-IR index and hyperglycemic clamp.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bruno Geloneze Neto.

Rights and permissions

Open Access  This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.

The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/.

The Creative Commons Public Domain Dedication waiver (https://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ribeiro, F.B., de Cássia da Silva, C., Vasques, A.C.J. et al. Hypertriglyceridemic waist phenotype indicates insulin resistance in adolescents: validation study front hyperglycemic clamp-Brazilian Metabolic Syndrome Study (BRAMS). Diabetol Metab Syndr 7 (Suppl 1), A145 (2015). https://doi.org/10.1186/1758-5996-7-S1-A145

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/1758-5996-7-S1-A145

Keywords